Hi-Tech Pharmacal Income Statement
View: Annual | Quarterly
| Quarter Ending Jul 09 |
Quarter Ending Apr 09 |
Quarter Ending Jan 09 |
Quarter Ending Jan 09 |
Quarter Ending Oct 08 |
|
|---|---|---|---|---|---|
| Revenue | 43.5 | 38.3 | 29.4 | 29.4 | 25.1 |
| Cost of Goods Sold | 16.9 | 18.4 | 15.6 | 15.6 | 13.1 |
| Gross Profit | 26.6 | 19.9 | 13.8 | 13.8 | 12.0 |
| Gross Profit Margin | 61.1% | 52.0% | 47.0% | 47.0% | 47.7% |
| SG&A Expense | 12.7 | 10.6 | 9.3 | 9.3 | 7.5 |
| Depreciation & Amortization | -- | 3.6 | -- | -- | -- |
| Operating Income | -- | 7.8 | 3.5 | 3.5 | 2.9 |
| Operating Margin | -- | 20.2% | 11.8% | 11.8% | 11.5% |
| Nonoperating Income | -- | -- | 0.2 | 0.2 | 0.0 |
| Nonoperating Expenses | -- | -- | 0.5 | 0.5 | -- |
| Income Before Taxes | 13.9 | 7.7 | 3.5 | 3.5 | 2.9 |
| Income Taxes | 5.2 | 2.6 | 1.4 | 1.4 | 1.7 |
| Net Income After Taxes | 8.7 | 5.1 | 2.1 | 2.1 | 1.1 |
| Continuing Operations | 8.7 | 5.1 | 2.1 | 2.1 | 1.1 |
| Discontinued Operations | -- | -- | -- | -- | -- |
| Total Operations | 8.7 | 5.1 | 2.1 | 2.1 | 1.1 |
| Total Net Income | 8.7 | 5.1 | 2.1 | 2.1 | 1.1 |
| Net Profit Margin | 20.0% | 13.4% | 7.0% | 7.0% | 4.5% |
| Diluted EPS from Total Net Income ($) | 0.73 | 0.44 | 0.18 | 0.18 | 0.09 |
| Dividends per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
© 2009 Morningstar, Inc. Financial Data provided by
